


@article{Higgins1983IntranasalVolunteers,
    author = {Higgins, P. G. and Phillpotts, R. J. and Scott, G. M. and Wallace, J. and Bernhardt, L. L. and Tyrrell, D. A.},
    title = {Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers},
    journal = {Antimicrobial Agents and Chemotherapy},
    issn = {00664804},
    year = {1983},
    volume = {24},
    number = {5},
    pages = {713-715},
    doi = {10.1128/AAC.24.5.713}
    citedbycount = {49},
    abstract = {In a double blind, placebo-controlled study, self-administered intranasal human interferon Î±A produced by recombinant DNA technology was given both before and after virus challenge with a respiratory coronavirus. The incidence of colds, the severity of symptoms and signs, and virus replication were all reduced in subjects receiving interferon as compared with those given placebo.},
    keywords = {virus replication, respiratory coronavirus}
}
